CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME

This adverse event was reported 124 times

CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AXICABTAGENE CILOLEUCEL 115 0.0113
1 PROPARACAINE HYDROCHLORIDE 1 0.0019
2 SILTUXIMAB 1 0.0015
3 I. V. FAT EMULSION 1 0.0014
4 VANCOMYCIN HYDROCHLORIDE 10 0.0012
5 FILGRASTIM-SNDZ 3 0.0009
6 SODIUM CITRATE 1 0.0008
7 CHLOROTHIAZIDE 1 0.0008
8 ISAVUCONAZONIUM SULFATE 3 0.0008
9 ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE 1 0.0007
See all drugs enriched for association with CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME

CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 115 0.0113
1 Interleukin-6 Antagonist [EPC] 1 0.0015
2 Neuraminidase Inhibitor [EPC] 1 0.0004
3 Lipid Emulsion [EPC] 1 0.0004
4 Vitamin K [EPC] 3 0.0003
5 Plasma Volume Expander [EPC] 1 0.0003
6 Calcitonin [EPC] 1 0.0003
7 Gadolinium-based Contrast Agent [EPC] 1 0.0002
8 Antimalarial [EPC] 2 0.0002
9 Antiprotozoal [EPC] 2 0.0002
See all drug classes enriched for association with CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME